BBRC joins AD-RIDDLE’s second General Assembly in London

On 10–11 June 2025, the Barcelonaβeta Brain Research Centre (BBRC) participated in the second General Assembly of the AD-RIDDLE,  held in London and hosted by Imperial College London. The meeting brought together 24 partner organisations from across Europe to review progress and plan next steps in the effort to improve the detection, diagnosis, prevention, and treatment of Alzheimer’s disease.

The BBRC contributes to the project as a clinical site through a multidisciplinary team led by Dr. Marc Suárez-Calvet, group leader of the Fluid Biomarkers and Translational Neurology Research Group, focusing on the implementation of cognitive and blood biomarker studies.

The event featured presentations from project leaders Miia Kivipelto (Karolinska Institutet) and Niranjan Bose (Gates Ventures), who highlighted recent milestones and the importance of collaboration in overcoming barriers to Alzheimer’s care. Key sessions focused on the development of digital cognitive tools, real-world biomarker testing, and strategies to support clinical implementation.

Throughout the two-day meeting, participating partners also addressed project coordination, ethical considerations, and data-sharing frameworks to ensure the secure and effective use of clinical data across sites. 

BBRC is proud to collaborate on AD-RIDDLE and contribute to the transformation of Alzheimer’s research into tangible healthcare solutions.

More information about the meeting here.